Gefitinib Mylan

Gefitinib Mylan is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth.

Gefitinib Mylan is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or cannot be removed by surgery. It works by targeting and inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' and the answer lies in its ability to interfere with the cancer's growth mechanisms.

Common effects of Gefitinib Mylan may include skin rashes, diarrhea, and fatigue. Some users may also experience appetite loss or nausea. These effects can vary from person to person and are not exhaustive.

Gefitinib Mylan should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding its use. Pregnant women or those planning to become pregnant should discuss the risks with their doctor.

Gefitinib Mylan may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.